Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Suzhou Basecare Medical Corp. Ltd. Class H ( (HK:2170) ) has issued an update.
Suzhou Basecare Medical Corporation Limited has called its 2025 annual general meeting for June 4, 2026, in Suzhou, where shareholders will review key 2025 corporate reports, including board and supervisory reports, the annual report, and the group’s financial statements. They will also vote on the 2026 financial budget, the 2025 profit distribution plan, director remuneration, and the re-appointment of KPMG as auditor.
Shareholders will further consider granting the board general mandates to issue additional shares and repurchase H shares, as well as proposed amendments to the Articles of Association, moves that could provide the company with greater financial and capital management flexibility. The notice also outlines procedural details for proxy voting, poll-based resolution approval, and the share register closure period for H-shareholders entitled to participate in the meeting.
More about Suzhou Basecare Medical Corp. Ltd. Class H
Suzhou Basecare Medical Corporation Limited is a medical technology company based in Suzhou, Jiangsu Province, China, and listed in Hong Kong. The company operates in the healthcare and diagnostics sector, focusing on genetic testing and related medical solutions for the Chinese and broader Asian markets.
Average Trading Volume: 109,363
Technical Sentiment Signal: Sell
Current Market Cap: HK$527.9M
See more data about 2170 stock on TipRanks’ Stock Analysis page.